APA (7th ed.) Citation

Bozorgmehr, F., Hommertgen, A., Krisam, J., Kuon, J., Huber, P. E., König, L., . . . Thomas, M. (2019). Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer : study protocol of the FORCE trial. BMC cancer, 19, . https://doi.org/10.1186/s12885-019-6205-0

Chicago Style (17th ed.) Citation

Bozorgmehr, Farastuk, Adriane Hommertgen, Johannes Krisam, Jonas Kuon, Peter E. Huber, Laila König, Meinhard Kieser, Jürgen Debus, and Michael Thomas. "Fostering Efficacy of Anti-PD-1-treatment: Nivolumab Plus Radiotherapy in Advanced Non-small Cell Lung Cancer : Study Protocol of the FORCE Trial." BMC Cancer 19 (2019). https://doi.org/10.1186/s12885-019-6205-0.

MLA (9th ed.) Citation

Bozorgmehr, Farastuk, et al. "Fostering Efficacy of Anti-PD-1-treatment: Nivolumab Plus Radiotherapy in Advanced Non-small Cell Lung Cancer : Study Protocol of the FORCE Trial." BMC Cancer, vol. 19, 2019, https://doi.org/10.1186/s12885-019-6205-0.